- Raised $10M funding round led by Guangzhou Sino-Israel Biotech Investment Fund (GIBF), May 2024
- Raised $13.6M funding round led by Peregrine Ventures, Dec 2022
- Raised $5.4M funding round, Mar 2022
About
Nectin Therapeutics is a biotechnology company devoted to transforming the lives of cancer patients by the development of next-generation immune-oncology (IO) therapies. The company is dedicated to the development of novel therapeutic options for cancer patients. It is developing a diverse pipeline of targeted antibodies based on the nectin pathways. These antibodies overcome inhibitory pathways deployed by the tumors and allow immune cells to effectively destroy cancer cells. Additionally, based on the unique expression patterns of several nectin proteins, it develops CAR-T and -NK drivers that directly target tumor cells in various indications, including hard-to-treat cancers. The company was established based on seminal research at the Hebrew University of Jerusalem and the University of Rijeka. Its technology addresses major escape mechanisms of current IO therapies through a diverse pipeline of novel monoclonal antibodies and antibody-drug-conjugates.
Funding history · 6 rounds · $36.0M total
Q&A
- What is Nectin Therapeutics' primary focus?
- Nectin Therapeutics is a biotechnology company dedicated to developing next-generation immune-oncology (IO) therapies to transform the lives of cancer patients.
- When was Nectin Therapeutics founded?
- Nectin Therapeutics was founded in January 2017.
- What is Nectin Therapeutics' current employee count?
- Nectin Therapeutics has 11-50 employees.
- What is Nectin Therapeutics' total funding to date?
- Nectin Therapeutics has raised a total of $36,000,000 USD.
- Which investors participated in Nectin Therapeutics' May 2024 funding round?
- In May 2024, Guangzhou Sino-Israel Biotech Investment Fund (GIBF) invested in Nectin Therapeutics.
- Who led Nectin Therapeutics' December 2022 funding round?
- The December 2022 funding round for Nectin Therapeutics was led by.
- Who is the CEO of Nectin Therapeutics?
- Fabian Tenenbaum is the CEO of Nectin Therapeutics.
- What is the product stage of Nectin Therapeutics?
- Nectin Therapeutics' product is in the clinical trial stage.
- Where is Nectin Therapeutics headquartered?
- Nectin Therapeutics is headquartered in Jerusalem, Israel, with an additional office in Fort Lee, NJ, USA.
Team · 11
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | nectintx.com |
|---|---|
| linkedin.com/company/69206104 |
Identifiers & details
| Founded | 2017-1 |
|---|---|
| Employees (exact) | 11 |
| Offices | Fort Lee |
Radar intelligence
Patents
| EPO | 6 |
|---|
Web history (Wayback)
| Domain | nectintx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|